These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 5301950)

  • 21. Comparison of phentermine-amphetamine resin complex with sustained-release dextroamphetamine and placebo in the treatment of exogenous obesity.
    De Felice EA; Cohen A; Schmitz PL; Rothwell KG; Truant AP
    J Clin Pharmacol J New Drugs; 1968; 8(6):360-9. PubMed ID: 4883784
    [No Abstract]   [Full Text] [Related]  

  • 22. Fixed-dose combination of phentermine-topiramate for the treatment of obesity.
    Halpern B; Faria AM; Halpern A
    Expert Rev Clin Pharmacol; 2013 May; 6(3):235-41. PubMed ID: 23656337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hunger control with benzphetamine hydrochloride in the treatment of obesity].
    Linquette A; Fossati P
    Lille Med; 1971 Apr; 16():Suppl 2:620-4. PubMed ID: 5162097
    [No Abstract]   [Full Text] [Related]  

  • 24. [Phentermine resinate in obesity. Clinical trial of Mirapront in adipose children].
    Spranger J
    Munch Med Wochenschr; 1965 Sep; 107(38):1833-4. PubMed ID: 5323498
    [No Abstract]   [Full Text] [Related]  

  • 25. Hypotensive effect of fenfluramine in the treatment of obesity.
    Practitioner; 1971 Jul; 207(237):101-5. PubMed ID: 5557039
    [No Abstract]   [Full Text] [Related]  

  • 26. [Patterns of glucose and pyruvate curves during treatment of obesity with chlorphentermine (Avipron)].
    Adamska-Dyniewska H; Kowalczyk L
    Wiad Lek; 1968 Nov; 21(21):1901-4. PubMed ID: 5714921
    [No Abstract]   [Full Text] [Related]  

  • 27. Orlistat for obesity.
    Med Lett Drugs Ther; 1999 Jun; 41(1055):55-6. PubMed ID: 10436767
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of obesity with a new lipolytic and anorexigenic drug: phenproporex].
    Luquero Campos F
    Rev Esp Enferm Apar Dig; 1971 Apr; 34(1):91-8. PubMed ID: 5564856
    [No Abstract]   [Full Text] [Related]  

  • 29. The pharmacologic management of obesity.
    Cerda JJ
    J Fla Med Assoc; 1997 Feb; 84(2):89-92. PubMed ID: 9066231
    [No Abstract]   [Full Text] [Related]  

  • 30. Desopimon in the management of obesity associated with heart disease.
    Gonda F; Kenedi I
    Ther Hung; 1973; 21(2):82-4. PubMed ID: 4792883
    [No Abstract]   [Full Text] [Related]  

  • 31. Lemons for obesity.
    Lauer MS
    Ann Intern Med; 2012 Jul; 157(2):139-40. PubMed ID: 22801677
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinically controlled trial of Perphoxene].
    Barbey JD
    Schweiz Rundsch Med Prax; 1971 Sep; 60(37):1242-6. PubMed ID: 4937701
    [No Abstract]   [Full Text] [Related]  

  • 33. Anorectic therapy and valvular heart disease: a reappraisal.
    Silvestry FE; St John Sutton M
    Eur Heart J; 1999 Jul; 20(13):917-20. PubMed ID: 10361039
    [No Abstract]   [Full Text] [Related]  

  • 34. A comparative trial of fenfluramine and diethylpropion inbesity.
    Silverstone JT; Cooper RM; Begg RR
    Br J Clin Pract; 1970 Oct; 24(10):423-5. PubMed ID: 4923926
    [No Abstract]   [Full Text] [Related]  

  • 35. Obesity.
    Arterburn D
    Clin Evid; 2003 Dec; (10):676-89. PubMed ID: 15555115
    [No Abstract]   [Full Text] [Related]  

  • 36. [Fenfluramine. Anorexigenic drug in obstetrical practice].
    Ramírez Soto E; Delgado Urdapilleta J
    Ginecol Obstet Mex; 1969 Apr; 25(150):425-32. PubMed ID: 5814199
    [No Abstract]   [Full Text] [Related]  

  • 37. TDrug therapy in obesity.
    Ruedy J
    Mod Treat; 1967 Nov; 4(6):1138-45. PubMed ID: 6080141
    [No Abstract]   [Full Text] [Related]  

  • 38. Obesity.
    Arterburn D; DeLaet D; Flum D
    Clin Evid; 2005 Jun; (13):707-25. PubMed ID: 16135277
    [No Abstract]   [Full Text] [Related]  

  • 39. [Study of the action of concentrated lucofen with prolonged effect].
    Godefroy G; Napolier A; Andriambao-Damasy S
    Mars Med; 1968; 105(3):289-93. PubMed ID: 5739899
    [No Abstract]   [Full Text] [Related]  

  • 40. Anti-lipaemic effect of Desopimon in obesity and in diabetes mellitus accompanied by obesity.
    Less E
    Ther Hung; 1974; 22(1):27-31. PubMed ID: 4844928
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.